Abiopharma

🔍 Chen Liaohan (Executive)

Company: Tuya Inc. (TUYA)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 237 shares of Class A Common Stock (Direct)
  Date: 2026-04-24 | Code: J | equity_swap_involved: false | shares_owned_after: 1,989,337.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 237 shares of Class B Common Stock (Direct)
  Date: 2026-04-24 | Code: J | equity_swap_involved: false | shares_owned_after: 26,810,663.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: On April 24, 2026, the Company canceled 5,400 repurchased Class A ordinary shares. As this cancellation reduced the total number of shares in issue, absent any corresponding adjustment, the proportion of shares carrying weighted voting rights (WVR) would have increased. Accordingly, in compliance with Rule 8A.15 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, Mr. Chen, as a WVR beneficiary, caused Unileo Limited to convert 237 Class B ordinary shares into Class A ordinary shares on a one-for-one basis, so as to reduce his weighted voting rights proportionately.
• F2: Represent shares held through Unileo Limited, a limited liability company incorporated under the laws of BVI wholly owned by the reporting person.